ClinicalTrials.gg
Drug

Poractant alfa clinical trials

Also written Curosurf.

studies test it
20
open now
5
in phase 3
2
first study started
2005

How each study uses poractant alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the poractant alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Nov 1999 · CUROSURF · BLA 020744 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Poractant alfa
8
Poractant alfa (Curosurf®)
2
Poractant Alfa Intratracheal Suspension [Curosurf]
2

Brand

Curosurf
8

Studies by the year they started

20 studies that test it; most in 2021 (4)

Studies that test poractant alfa, by start year
YearStudies
20051
20071
20092
20101
20111
20121
20132
20171
20191
20202
20214
20241
20262

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
Phase 3
2
Phase 4
8
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 17

Chiesi Farmaceutici S.p.A. (3) · Dr. Sami Ulus Children's Hospital (2) · University of Michigan (2) · Jean Michel Hascoet (1) · University of Missouri-Columbia (1) · Zekai Tahir Burak Women's Health Research and Education Hospital (1) · University of Cologne (1) · Hospital Clinic of Barcelona (1)

Often tested with

Tested in the same studies.

Beractant (3) · Calfactant (2) · Budesonide (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test poractant alfa.

Studies

Open first, then newest update. How each study uses poractant alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

Given beside what is tested · 2 — poractant alfa is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with poractant alfa

Codes

What other systems call poractant alfa · ClinicalTrials.gg INT003561

  • MeSH (NLM) C068291poractant alfaConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) KE3U2023NPPORACTANT ALFAConfirmed FDA, NLM, Wikidata
  • RxNorm 236381Confirmed FDA, Wikidata
  • Wikidata Q15708403poractant alfaConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81353Poractant AlfaConfirmed FDA, Wikidata
  • DrugBank DB09113One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.